Skip to Content

Join the 'EEMT DS' group to help and get support from people like you.

EEMT DS News

Could an Estrogen Patch Boost Women's Sex Lives in Menopause?

Posted 28 Aug 2017 by Drugs.com

MONDAY, Aug. 28, 2017 – Women in early menopause who feel their sex drive or function is lagging may want to consider help from an estrogen "patch," new research suggests. In the new study, "we show that [supplemental] estrogens can also be beneficial for sexual function," said study lead author Dr. Hugh Taylor of Yale School of Medicine. His group published the findings Aug. 28 in JAMA Internal Medicine. The study addresses a key – but often unreported – effect of menopause, one expert said. "One of the chief complaints of menopause is changes in sexual function," said Dr. Jennifer Wu, an obstetrician/gynecologist at Lenox Hill Hospital in New York City. "Many women are very fearful of these changes and what it will mean for their relationships. Many women also think the decreases in arousal, desire, lubrication and orgasm are inevitable." For the study, Taylor's team tracked ... Read more

Related support groups: Hot Flashes, Estradiol, Menopausal Disorders, Estrace, Postmenopausal Symptoms, Vagifem, Estrace Vaginal Cream, Vivelle, Atrophic Vaginitis, Climara, Estring, Natazia, Estratest, Vivelle-Dot, Estradiol Patch, Perimenopausal Symptoms, Estradiol/Norethindrone, Angeliq, Minivelle, Evamist

Hormone Therapy Not Advised for Preventing Disease After Menopause

Posted 16 May 2017 by Drugs.com

TUESDAY, May 16, 2017 – Using hormone therapy to prevent chronic health issues, such as heart disease and bone loss, in postmenopausal women may do more harm than good, the U.S. Preventive Services Task Force (USPSTF) says. After reviewing current evidence, the task force has issued an updated draft recommendation, reaffirming its final statement issued in 2012. The expert panel advises against the use of hormones – including estrogen and progestin – to prevent chronic conditions among postmenopausal women, including those who've had their uterus removed. Hormone therapy in postmenopausal women first came under scrutiny in 2002, when a large U.S. trial known as the Women's Health Initiative abruptly halted a look at the benefits and harms of hormone therapy because it appeared to raise the risks of breast cancer, heart attack, stroke and blood clots. Women typically enter menopause ... Read more

Related support groups: Hot Flashes, Menopausal Disorders, Osteoporosis, Progesterone, Postmenopausal Symptoms, Fracture, bone, Prometrium, Atrophic Vaginitis, Prevention of Osteoporosis, Estratest, Perimenopausal Symptoms, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction, Dyspareunia, Crinone, Estratest HS, Esterified Estrogens/Methyltestosterone, Atrophic Urethritis, Esterified Estrogens, Menest

HRT Won't Lower Women's Alzheimer's Risk, Study Finds

Posted 16 Feb 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – Women who use hormone therapy after menopause may not have a lower risk of developing Alzheimer's, a new study suggests. However, there was some evidence that long-term use – over a decade – might be tied to a lower risk of the memory-robbing brain disease. But the results were far from definitive, the researchers added. The study is the latest to delve into the question of whether menopausal hormone therapy can benefit women's brains. Research so far has yielded conflicting findings. On one hand, a number of trials have found no brain benefits for women using hormone therapy, said Dr. JoAnn Pinkerton, executive director of the North American Menopause Society. On the other hand, small trials have found that when hormone therapy is given after surgical menopause, women can see "cognitive benefits," said Pinkerton, who was not involved in the new study. On ... Read more

Related support groups: Plan B, Provera, Mirena, Nexplanon, Depo-Provera, NuvaRing, Sprintec, Implanon, Ortho Tri-Cyclen, Hot Flashes, Tri-Sprintec, Microgestin Fe 1/20, Yasmin, Loestrin 24 Fe, Plan B One-Step, Ortho Evra, TriNessa, Estradiol, Lutera, Menopausal Disorders

Earlier Hormone Therapy May Pose Less Risk for Menopausal Women

Posted 30 Sep 2015 by Drugs.com

WEDNESDAY, Sept. 30, 2015 – Women who start hormone therapy toward the beginning of menopause may have a lower risk of developing heart disease, new research suggests. The study, of over 74,000 Swedish women, found that those who started hormone therapy within five years of beginning menopause typically stayed free of heart disease for a longer time than non-users. In contrast, women who started hormone therapy later showed an increase in their heart disease risk. "This is in line with what a number of studies have shown," said Dr. Sonia Tolani, of the Women's Center for Cardiovascular Health at New York-Presbyterian Hospital, in New York City. "There does seem to be a relationship between the timing of hormone therapy and heart disease risk," said Tolani, who was not involved in the study. However, she stressed, that doesn't mean women should routinely use hormones when menopause ... Read more

Related support groups: Plan B, Provera, Mirena, Nexplanon, Depo-Provera, Implanon, Hot Flashes, Microgestin Fe 1/20, Loestrin 24 Fe, Plan B One-Step, Estradiol, Menopausal Disorders, Lo Loestrin Fe, Medroxyprogesterone, Premarin, Levonorgestrel, Ethinyl Estradiol, Progesterone, Estrace, Junel Fe 1/20

Ask a Question

Further Information

Related Condition Support Groups

Menopausal Disorders, Postmenopausal Symptoms, Hot Flashes

EEMT DS Patient Information at Drugs.com